Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism
NCT02728440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2016-04-13
Summary
Effects of gonadotrophin replacement therapy Lipid Profile and Oxidative Stress Parameters of Patients with Idiopathic Hypogonadotropic Hypogonadism
Conditions
- Idiopathic Hypogonadotropic Hypogonadism
Interventions
- DRUG
-
human chorionic gonadotropin, human menopausal gonadotropin
drug for the treatment of male hypogonadism
Sponsors & Collaborators
-
Gulhane School of Medicine
lead OTHER
Eligibility
- Min Age
- 22 Years
- Max Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
More Related Trials
-
Oral Testosterone for the Treatment of Hypogonadism
NCT01717768 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism
NCT02111473 ·Status: COMPLETED ·Phase: PHASE4
-
Testosterone Undecanoate and Quality of Life of Men and Spouses
NCT01758029 ·Status: UNKNOWN
-
Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man
NCT02847806 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Testosterone Replacement on Insulin Resistance
NCT00487734 ·Status: COMPLETED ·Phase: PHASE4
-
Testosterone Gel Applied to Women With Pituitary Gland Problems
NCT00144391 ·Status: COMPLETED ·Phase: PHASE4
-
Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment
NCT02111434 ·Status: COMPLETED ·Phase: PHASE4
-
Pubertal Induction in Individuals With Hypogonadism
NCT02871986 ·Status: UNKNOWN
-
Metabolomics During Testosterone Therapy
NCT01963390 ·Status: COMPLETED
-
Sequential Therapy for Hypogonadotropic Hypogonadism
NCT01403532 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups
NCT01454011 ·Status: COMPLETED ·Phase: PHASE4
-
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
NCT02159469 ·Status: COMPLETED ·Phase: PHASE3
-
Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
NCT03887936 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Testosterone for the Treatment of Hypogonadism in Males
NCT02222558 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)
NCT03118479 ·Status: TERMINATED ·Phase: PHASE1
-
Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes
NCT00479609 ·Status: UNKNOWN ·Phase: PHASE3
-
Leuprolide in Determining the Cause of Gonadotropin Deficiency
NCT00004426 ·Status: COMPLETED ·Phase: NA
-
Opioid Antagonism in Hypogonadotropic Hypogonadism
NCT04975334 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Response of Gonadal Steroids and Bone Turnover in Older Men
NCT00114114 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845
NCT04673682 ·Status: COMPLETED ·Phase: PHASE1
-
Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy
NCT02171390 ·Status: COMPLETED ·Phase: PHASE4
-
Androgen Replacement Therapy in Women With Hypopituitarism
NCT00027430 ·Status: COMPLETED ·Phase: NA
-
Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men
NCT00470990 ·Status: COMPLETED ·Phase: NA
-
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
NCT07278362 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4